because it was both the cohort 3 and the report.
they needed to socialise the report with those who contributed, get the green light from the safety committee as well as inform the market. Trading halt allows them to get the first done before reporting to the market (sequence activities)
Ann: PharmAust MND Trial Interim Analysis PK Outcomes, page-18
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $111.9M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $289.4K | 1.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 149248 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 6664 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |